Arginine methylation regulates the p53 response

被引:368
作者
Jansson, Martin [1 ]
Durant, Stephen T. [1 ]
Cho, Er-Chieh [1 ]
Sheahan, Sharon [1 ]
Edelmann, Mariola [2 ]
Kessler, Benedikt [2 ]
La Thangue, Nicholas B. [1 ]
机构
[1] Univ Oxford, Canc Biol Lab, Dept Clin Pharmacol, Div Med Sci, Oxford OX3 7DQ, England
[2] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7BN, England
基金
英国医学研究理事会;
关键词
D O I
10.1038/ncb1802
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Activation of the p53 tumour suppressor protein in response to DNA damage leads to apoptosis or cell-cycle arrest. Enzymatic modifications are widely believed to affect and regulate p53 activity. We describe here a level of post-translational control that has an important functional consequence on the p53 response. We show that the protein arginine methyltransferase (PRMT) 5, as a co-factor in a DNA damage responsive co-activator complex that interacts with p53, is responsible for methylating p53. Arginine methylation is regulated during the p53 response and affects the target gene specificity of p53. Furthermore, PRMT5 depletion triggers p53-dependent apoptosis. Thus, methylation on arginine residues is an underlying mechanism of control during the p53 response.
引用
收藏
页码:1431 / U122
页数:19
相关论文
共 30 条
[1]   Arginine methylation: An emerging regulator of protein function [J].
Bedford, MT ;
Richard, S .
MOLECULAR CELL, 2005, 18 (03) :263-272
[2]   PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins [J].
Branscombe, TL ;
Frankel, A ;
Lee, JH ;
Cook, JR ;
Yang, ZH ;
Pestka, S ;
Clarke, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (35) :32971-32976
[3]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[4]   The role of tetramerization in p53 function [J].
Chène, P .
ONCOGENE, 2001, 20 (21) :2611-2617
[5]   Mdm2 targets the p53 transcription cofactor JMY for degradation [J].
Coutts, Amanda S. ;
Boulahbel, Houda ;
Graham, Anne ;
La Thangue, Nicholas B. .
EMBO REPORTS, 2007, 8 (01) :84-90
[6]   The p53 response: Emerging levels of co-factor complexity [J].
Coutts, AS ;
La Thangue, NB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (03) :778-785
[7]   Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome [J].
Davison, TS ;
Yin, P ;
Nie, E ;
Kay, C ;
Arrowsmith, CH .
ONCOGENE, 1998, 17 (05) :651-656
[8]   A new effector pathway links ATM kinase with the DNA damage response [J].
Demonacos, C ;
Krstic-Demonacos, M ;
Smith, L ;
Xu, DM ;
O'Connor, DP ;
Jansson, M ;
La Thangue, NB .
NATURE CELL BIOLOGY, 2004, 6 (10) :968-+
[9]   A TPR motif cofactor contributes to p300 activity in the p53 response [J].
Demonacos, C ;
Krstic-Demonacos, M ;
La Thangue, NB .
MOLECULAR CELL, 2001, 8 (01) :71-84
[10]   APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death [J].
Fortin, A ;
Cregan, SP ;
MacLaurin, JG ;
Kushwaha, N ;
Hickman, ES ;
Thompson, CS ;
Hakim, A ;
Albert, PR ;
Cecconi, F ;
Helin, K ;
Park, DS ;
Slack, RS .
JOURNAL OF CELL BIOLOGY, 2001, 155 (02) :207-216